def get_data():
  return {'SARS-Cov-2': {'clonazepam': 1, 'methylprednisolone': 1, 'ocrelizumab': 1, '12/08/2021': 1, 'FIBTEM': 1, 'Thromboelastometric': 1, 'dimethyl fumarate (DMF)': 1, 'Chan Zuckerberg Biohub (JLD)': 1, 'RObust': 1, 'Shufeng': 1, 'TCMSP': 1, 'TCMID': 1, 'Kyoto': 2, 'Quercetin': 1, 'Baicalein': 1, 'Glabrene': 1, 'Glucobrassicin': 1, 'Isoglycyrol': 1, 'Luteolin': 1, 'thyrotoxic': 1, 'casirivimab': 2, 'imdevimab': 3, 'Casirivimab': 1, 'imdevimab antibody combination vs': 1, 'betamethasone sodium phosphate/fradiomycin sulfate': 1, '6MP': 1, 'azathioprine': 1, 'methotrexate': 1, 'sulfasalazine': 1, 'immunosuppressive medications': 1, 'hormone melatonin': 1, 'luteolin': 1, 'quercetin': 1, 'amino acid transport': 1, 'amino acids': 1, 'heparin': 4, 'antibiotics': 1, 'aspirin': 1, 'hydrocortisone': 2, 'antifungal': 2, 'Coronaviridae': 2, 'hydroxychloroquine': 1, 'azithromycin': 1, 'Corticosteroids': 1, 'cyclophosphamide': 3, 'October': 2, 'packed red blood cell (pRBC)': 1, 'steroids': 2, 'Pfizer': 1, 'angiotensin receptor blocker (ARB)': 1, 'diuretics': 1, 'LHQW': 1, 'AYUSH': 1, 'Unani': 1, 'CYC': 1, 'rituximab': 2, 'folic acid': 1, 'Cepko': 1, 'dUTP': 1, 'uracil': 1, 'mineral oil': 1, 'polyethylene glycol (PEG)-NaCl, incubation period': 1, 'PEG-NaCl': 1, 'steroid': 2, 'estradiol': 3, 'progesterone': 1, 'testosterone': 1, 'dexamethasone': 1, 'prednisone': 1, 'calcitriol': 4, 'Sinovac': 2, 'Latinx': 2, 'Bryopsidophyceae': 1, 'Chlorophyta': 1, 'sulfate substitution': 1, 'Comirnaty': 1, 'monoclonal antibody': 1, 'August': 1}, 'infection': {'Antibiotic': 3, 'antibiotic': 6, 'rifampicin': 1, 'immunomodulation': 1, 'clonazepam': 1, 'methylprednisolone': 1, 'ocrelizumab': 1, 'injectables': 2, '12/08/2021': 1, 'February': 2, 'eligilibity': 1, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'AE.BACKGROUND': 1, 'dimethyl fumarate (DMF)': 1, 'Chan Zuckerberg Biohub (JLD)': 1, 'MDRPIs': 1, 'SSI': 4, 'vacuolar': 1, 'corticosteroids': 1, 'tacrolimus': 1, 'compound trimethoprim-sulfamethoxazole (SMX-TMP)': 1, 'caspofungin': 1, 'SCPP': 1, 'FIO2': 1, 'Clozapine': 1, 'clozapine': 3, 'aminoglycosides': 1, 'tobramycin': 6, 'January': 2, 'September': 1, 'vasopressor': 1, 'Ophidiomycosis': 1, 'casirivimab': 2, 'imdevimab': 3, 'Casirivimab': 1, 'imdevimab antibody combination vs': 1, 'macrolide': 1, 'clarithromycin': 1, 'macrolides': 1, 'dopamine': 1, 'CAEBV': 1, 'chemotherapy': 1, 'interferon-alpha treatment': 1, 'ceftazidime': 2, 'cefepime': 1, 'Antibiotics': 1, 'oxacillin': 1, 'teicoplanin': 1, 'daptomycin': 1, 'fosfomycin': 1, 'antibiotics': 6, 'hormone melatonin': 1, 'instillation': 1, 'rTc-ASA,': 1, 'supplemental zinc': 1, 'enterica': 1, 'supplemented': 1, 'zinc': 1, 'zinc supplementation improved the intestinal mucosal morphology and enhanced the immune response, as well as activated': 1, 'amino acid transport': 1, 'amino acids': 1, 'betadine': 5, 'vancomycin': 3, '30-': 1, 'bevacizumab': 1, 'Vancomycin': 1, 'CTL': 2, 'sCMV': 2, 'interferon alpha/peginterferon alpha (IFNalpha/Peg-IFNalpha)': 1, 'primaquine': 5, 'artemisinin': 2, 'dihydroartemisinin': 3, 'pyronaridine': 2, 'mycobiome': 1, 'Finland': 1, '098': 1, 'aspirin': 1, 'hydrocortisone': 1, 'Blepharis ciliaris (98%)': 1, 'Blepharis ciliaris': 1, 'Rhizophagus': 1, 'allopurinol': 2, 'antifungal': 2, 'voriconazole': 1, 'levofloxacin': 6, 'chitosan': 1, 'cysticercosis': 2, '245/1,673': 1, 'acyclovir': 3, 'valacyclovir': 1, 'Immunomodulatory agents (thalidomide and topical imiquimod)': 1, 'thalidomide': 1, 'imiquimod': 1, 'cidofovir': 1, 'Levofloxacin': 1, 'diuretic': 1, 'analgesic': 1, 'epigallocatechin gallate and protected oral epithelial cells': 1, 'cetylpyridinium chloride': 1, 'benzethonium chloride': 1, 'nonselective beta-blockers (OR = 0.294': 1}, 'pandemic': {'September': 2, 'buprenorphine': 8, 'opioid': 4, 'mu opioid agonist': 1, 'opioids': 1, 'full agonist opioids': 1, 'chronic buprenorphine': 1, 'October': 2, 'GARCH': 1, 'Diebold': 1, 'November': 1, 'overdoses': 1, 'naloxone': 8, 'Naloxone': 1, 'narcotic': 1, 'February': 1, 'January': 3, 'chemotherapy': 1, 'Pfizer': 2, 'antimicrobials': 1, 'Instagram': 4, 'Facebook': 1, '245/1,673': 1, 'AYUSH': 1, 'Unani': 1, 'polyethylene glycol (PEG)': 1, 'Basophil Histamine Release (BaHR)': 1, 'steroids': 2, 'laxatives': 1, 'BioNTech vaccine': 1, 'August': 3, '2021;25(12):1382': 1, 'methylprednisolone': 2, 'dexamethasone': 2, 'HFNC': 2, 'Wuhan': 1, 'HTP': 1, 'extracellular nicotinamide phosphoribosyltransferase (eNAMPT)': 1, 'eNAMPT': 2, 'heparin': 1, 'immunomodulators': 1, 'tocilizumab': 2}, 'death': {'tisagenlecleucel': 2, 'chemo': 5, 'doxorubicin': 2, 'methylene blue': 1, 'PD-1 checkpoint blockade further evokes a series of systemic immunity responses that suppress distant tumor growth and the pulmonary metastasis of breast cancer, as well as offer': 1, 'October': 2, 'oxaliplatin': 5, 'chemotherapy': 20, 'nivolumab': 8, 'capecitabine': 1, 'Nivolumab': 1, 'antiarrhythmic': 2, 'amiodarone': 3, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'porcine Kobuvirus (PKoV)': 1, 'mRNAs': 2, 'trametinib': 3, 'spartalizumab': 1, 'statin': 1, 'vitamin K': 1, 'vitamin K supplementation': 1, 'Vitamin K supplementation is required': 1, 'Amantadine': 1, 'modafinil': 7, 'amantadine': 7, 'sedative medications': 1, 'SOC therapies': 1, 'amphetamines': 1, 'amphetamine': 1, 'antipsychotic': 4, 'antipsychotics': 5, 'unresectable': 1, 'gemcitabine': 2, 'Toripalimab': 1, 'PMCT': 2, 'PMMRI': 2, 'CAEBV': 1, 'interferon-alpha treatment': 1, 'PD-1 antibody pembrolizumab': 1, 'betamethasone': 1, 'montelukast': 1, 'salbutamol': 1, 'salmeterol': 1, 'fluticasone': 1, 'TBI': 1, 'FQ': 1, 'sotagliflozin': 1, 'Immunochemical': 1, 'antiplatelet': 1, 'aspirin': 4, 'Antiplatelet': 1, 'Intramuscular': 1, 'MgSO4': 2, 'magnesium': 1, 'heparin': 1, 'mono antiplatelet therapy': 1, 'antifungal': 1, 'propolis': 1, 'phenol': 1, 'Datalink': 1, 'cysticercosis': 2, 'January': 2, 'artemisinin': 1, 'GLS': 1, 'iron ion': 1, 'Fe(2+)generation': 1, 'oxygen': 1, 'scavenge reactive oxygen': 1, 'antacids': 1, 'H2 blockers': 1, 'Lohani': 1, 'diuretic': 1, 'JMJD2D inhibitor': 1, 'steroid': 2, 'estradiol': 3, 'progesterone': 1, 'testosterone': 1, 'dexamethasone': 1, 'hydrocortisone': 1, 'prednisone': 1, 'calcitriol': 4, 'antibiotic': 1, 'antibiotics': 3}, 'cancer': {'oxygen': 1, 'Turkey': 1, 'November': 1, 'doxorubicin': 5, 'acyl hydrazine': 1, 'thiourea': 1, 'humanized monoclonal antibody': 1, 'nanoforms': 1, 'EXO1': 1, 'pillararenes': 1, 'chemo': 5, 'methylene blue': 1, 'PD-1 checkpoint blockade further evokes a series of systemic immunity responses that suppress distant tumor growth and the pulmonary metastasis of breast cancer, as well as offer': 1, 'O(6)-CMG': 1, 'chemotherapy': 26, 'bevacizumab': 1, 'LR': 1, 'oxaliplatin': 6, 'nivolumab': 8, 'capecitabine': 2, 'Nivolumab': 1, 'Arsenic trioxide (ATO)': 1, 'ctDNA': 2, 'Corepressors': 1, 'IQR': 1, 'gefitinib': 2, 'CHT': 1, 'TT': 1, 'erlotinib': 1, 'PFS': 2, 'OS': 1, 'IL-6': 1, 'PEGlyated macrocyclic': 1, 'RObust': 1, 'TLR agonists': 4, 'TLR agonists (2011-2014)': 1, 'TLR agonists (2015-2019)': 1, 'January': 3, 'hyaluronic acid (HA)': 1, 'statin': 5, 'Statin': 1, 'Kyoto': 2, 'FOS': 1, 'IKBKE': 1, 'MBSR': 1, 'rapamycin': 1, 'ATCC': 1, 'K inhibitor therapy in ER-positive metastatic patients)': 1, 'CINAHL': 1, 'Scopus': 2, 'Cochrane': 1, 'PSMA ligands': 1, 'glutamic acid into a lysine residue': 1, 'August': 1, 'progesterone': 1, 'desogestrel': 1, 'norethindrone': 1, 'megestrol': 1, 'norprogesterones': 1, 'levonorgestrel': 2, 'tamoxifen': 1, 'Facebook': 1, 'Instagram': 1, 'immunotherapy': 1, 'checkpoint inhibitor': 1, 'CRL': 3, 'February': 1, 'dmit': 1, 'dsit ligands': 1, 'cisplatin': 3, 'CRISPR': 1, 'Ncadherin': 1, 'vimentin': 1, 'ZNF384 knockdown models were established in CRC cells': 1, 'MMP2': 1, 'bazedoxifene': 5, 'paclitaxel': 7, 'CAFs': 2, 'lactic acid efflux': 1, 'anticancer': 1, 'dimethyl arsenic acid (DMA)': 1, 'toluidine blue (Tb)': 1, 'DNAzyme': 1, 'nicotinamide adenine dinucleotide (NADH)': 1, 'unresectable': 1, 'gemcitabine': 3, 'Toripalimab': 2, 'osimertinib': 1, 'pemetrexed': 1, 'icotinib': 1, 'letrozole': 1, 'carboplatin': 1, 'etoposide': 1, 'consolidative': 1, 'PD-1 antibody pembrolizumab': 1, 'betamethasone': 1, 'montelukast': 1, 'salbutamol': 1, 'salmeterol': 1, 'fluticasone': 1, 'Antibiotic': 1, 'antibiotic': 5, 'EOCRC': 1, 'antibiotics': 1}, 'coronavirus disease 2019': {'oxygen': 2, '12/08/2021': 1, 'Mefenamic acid': 1, 'nonsteroidal': 1, 'antipyretic': 1, 'analgesic': 1, 'mefenamic acid combined with standard medical care vs. standard medical care plus a placebo in ambulatory patients with coronavirus disease 2019 (COVID19; nasal/oropharyngeal swabs reverse transcriptionPCR test results positive for severe acute respiratory syndrome coronavirus 2)': 1, 'doubleblind': 1, 'mefenamic acid group (P=0.020, KaplanMeier analyses using logrank tests)': 1, 'mefenamic acid plus standard medical care had a': 1, 'mefenamic acid group': 1, 'mefenamic acid markedly reduced the symptomatology and time to reach PASS in ambulatory patients with COVID19': 1, 'mefenamic acid': 1, 'September': 5, 'amino acid transport': 1, 'Instagram': 4, 'Facebook': 1, 'antifungal': 2, 'voriconazole': 1, 'Khulna': 1, '245/1,673': 1, 'steroids': 2, 'cyclophosphamide': 2, 'Pfizer': 2, 'AstraZeneca': 2, 'CYC': 1, 'rituximab': 1, 'polyethylene glycol (PEG)-NaCl, incubation period': 1, 'PEG-NaCl': 1, 'Embase': 1, 'Scopus': 1, 'February': 1, 'Lohani': 1, 'August': 2, 'January': 1, '2021;25(12):1382': 1, 'methylprednisolone': 6, 'dexamethasone': 2, 'HFNC': 2, 'heparin': 1, 'telementoring': 2, 'NPIs': 1, 'intravitreal': 1, 'ranibizumab': 1, 'IMV': 1, 'Corticosteroids': 1, 'corticosteroids': 4, 'corticosteroid': 2, 'November': 3, 'antagonist monoclonal antibody': 1, 'tocilizumab': 4, 'chloroquine': 2, 'diuretics': 1, 'Hubei': 1, 'ivermectin': 1, 'azithromycin': 1, 'vitamin C': 1, 'zinc': 1, 'COVID-19)-directed': 1, 'vasopressors': 1, 'October': 1, 'vitamin D': 1, 'vitamin D3': 3}, 'SARS-CoV-2 infection': {'clonazepam': 1, 'methylprednisolone': 1, '12/08/2021': 1, 'dimethyl fumarate (DMF)': 1, 'Chan Zuckerberg Biohub (JLD)': 1, 'casirivimab': 2, 'imdevimab': 3, 'Casirivimab': 1, 'imdevimab antibody combination vs': 1, 'hydroxychloroquine': 1, 'azithromycin': 1, 'Corticosteroids': 1, 'cyclophosphamide': 1, 'Bryopsidophyceae': 1, 'Chlorophyta': 1, 'sulfate substitution': 1, 'February': 3, 'KFD': 1, 'continve': 1, 'amino acid substitution': 1, 'January': 1, 'corticosteroids': 3, 'inositol phosphate metabolism': 2, 'myofibroblast': 1, 'fibrogenesis': 1, 'STING': 1, 'Diasorin': 2, 'Saluggia': 1, 'Roche': 1, 'Human recombinant monoclonal antibodies (mAbs)': 1, 'heparan sulfate': 1, 'Coronavirinae': 1, 'Betacoronavirus': 1, 'BioNTech': 1, 'September': 4, 'bamlanivimab': 1, 'mRNA': 1, 'PRNT': 1, 'Amparo': 1, 'Pesquisa': 1, 'Bali': 1, 'Indonesia': 1, 'linagliptin': 2, 'insulin': 3, 'opioids': 1, 'Taipei': 2, 'August': 2, 'enoxaparin': 1, 'prednisone': 1, 'methotrexate': 1, 'October': 1, 'BCRSS': 1, '1OR': 1}, 'diabetes': {'aspirin': 7, 'exenatide (ITCA 650), recently reported its findings. METHODS: We meta-analysed its results with eight prior GLP-1 receptor agonists trials. RESULTS: GLP-1 receptor agonists reduced MACE by 13% (HR 0.87': 1, 'GLP-1 receptor agonists': 1, 'agonists': 1, 'glucagon': 2, 'PPAR agonists': 2, 'lanifibranor': 1, 'insulin': 17, 'midodrine': 1, 'droxidopa': 1, 'ciprofloxacin': 1, 'trametinib': 3, 'fasting insulin (P < .001)': 1, 'estradiol': 2, 'fasting insulin': 2, 'Clozapine': 1, 'clozapine': 3, 'vitamin D': 1, 'muPAD': 1, 'glucose': 2, 'Insulin': 3, 'August': 3, 'aOR': 2, 'noninsulin': 1, 'OmAq': 1, 'antipsychotic': 4, 'antipsychotics': 5, 'steroid': 2, 'Antibiotics': 1, 'oxacillin': 1, 'teicoplanin': 1, 'daptomycin': 1, 'fosfomycin': 1, 'antibiotics': 2, 'T2D': 1, '-4.8': 1, 'January': 3, 'antidepressants': 1, 'Engraftment': 1, 'Vitamin D supplementation during pregnancy is suggested': 1, 'vitamin D supplementation during pregnancy on biochemical markers (serum 25(OH)D, calcium, phosphorus and alkaline phosphatase)': 1, 'vitamin D supplementation:': 1, 'Vitamin D': 1, 'vitamin D supplementation of': 1, 'Kidcope': 1, 'CLN1': 1, 'CLN10': 1, 'serum glutamic oxaloacetic': 1, 'uric acid': 1, 'malondialdehyde': 1, 'GLP1Ra': 1, 'October': 1, 'vitamin D receptor (VDR, Fok I': 1, 'calcitonin receptor (CALCR': 1, 'estrogen receptor alpha (ESR1, Pvu II': 1, 'Visual Analog Scale (VAS)': 1, 'February': 2, 'testosterone': 1, 'sclerostin': 1, 'Embase': 2, 'Scopus': 1, 'superoxide dismutase': 1, 'metformin': 7, 'alendronate': 3, 'Alendronate': 1, 'fluids': 1, 'anticoagulants': 2, 'AnTicoagulation': 1, 'vitamin K antagonist': 1, 'corticosteroid': 1, 'alvarezii': 1, 'Kuala': 2, 'corneal insulin': 1, 'beta-cyclodextrin': 1, 'mucoadhesive': 1, 'Turkey': 1, 'analgesic': 1, 'Unani': 1, 'chemotherapy': 1, 'doxorubicin': 2, 'DLBCL': 1}, 'UC': {'Magnoliae': 1, 'trinitrobenzene sulfonic acid (TNBS)-induced ulcerative colitis (UC)': 1, 'TNBS': 1, 'probiotics': 2, 'Akkermansia': 1, 'Blautia': 1, 'Allobaculum': 1, 'Alloprevotella': 1, 'Ramucirumab': 1, 'docetaxel': 1, 'XOS': 1, 'Wilcoxon': 2, 'steroids': 3, 'steroid': 10, 'RNAscope': 1, 'chemo': 1, 'Pembrolizumab': 1, 'anticoagulation': 3, 'warfarin': 2, 'Phenytoin': 3, 'phenytoin': 3, 'hydrocortisone': 1, 'acetic acid': 1, 'PDGF': 1, 'chemotherapy': 5, 'RBO': 1, 'TRBO': 1, 'dextran sulfate sodium (DSS)': 1, 'Metabolomic': 1, 'JAK inhibitors': 1, 'JAK inhibitor': 3, 'ruxolitinib': 1, 'alteplase': 1, 'doxorubicin': 1, 'Golimumab': 2, 'immunomodulation': 1, 'UCMSCs': 3, 'AMMSCs': 2, 'carbamates pesticides': 1, 'superoxide dismutase (SOD)': 1, 'pharmacokinetics': 3, 'pharmacodynamics': 1, 'corticosteroids': 8, 'immunosuppressants': 1, 'Kyoto': 1, 'Nellore': 1, 'Prakasam': 1, 'nitric oxide': 1, 'terazosin': 2, 'thiobarbituric acid reactive substances (TBARS) concentration in plasma': 1, 'citrate': 1, 'budesonide': 2, 'infliximab': 31, 'adalimumab': 3, 'antibiotic': 1, 'systemic corticosteroid': 1, 'vedolizumab': 12, 'systemic corticosteroids': 1, 'antibiotics': 1, 'IQR': 1, 'Infliximab': 4, 'NSAID': 1, 'Itraconazole': 1, 'opioid': 3, 'Noviembre': 1, 'Colombia': 1, 'tofacitinib': 2, 'Adalimumab': 1, 'glucocorticoids': 2, 'mercaptopurine': 1, 'allopurinol': 1, 'PPI': 9, 'valacyclovir': 1, 'torsemide': 1, 'mesalamine': 6, 'losartan': 1, 'isoniazid': 1, 'prednisone': 2, 'azathioprine': 5, 'IBD meds': 1, 'corticosteroid': 4, 'certolizumab': 1, 'salicylates': 1, 'blood insulin (18.41 +/- 11.88 vs 6.4 +/- 4.26': 1, 'blood insulin': 1, 'JAK inhibitor regimen': 1, 'ASA': 2, 'immunomodulators': 1, 'ozanimod': 25, 'ozanimod HCl': 4, 'Europe': 1, 'Japan': 1, 'IBD': 1, 'dyyb': 4, 'methylprednisolone': 2, 'dyyb lacks monobasic sodium phosphate': 1, 'dibasic sodium phosphate': 1, 'HADS': 1, 'erbB': 1, 'DOFP': 1, 'DSS solution': 1, 'neferine': 1, 'SDDR': 1, 'Anandamide': 1, 'agonists': 1, 'mRNAs': 1, 'PCA1': 1, 'dextran sulfate sodium': 3, 'p62': 1, 'AMPK inhibitor compound C significantly reversed the anti-inflammatory effect of PCA1 in LPS-stimulated cells': 1, 'Janus kinase inhibitor': 1, 'Elabela': 2, 'PUBMED': 1, 'CINAHL': 1, 'EMBASE': 1, 'Monocytosis': 1, 'ginsenoside': 4, 'Lachnospiraceae': 1, 'AB aqueous': 1, 'Lactobacillus reuteri': 1, 'Lactobacillus': 1, 'urothelial': 1, 'pembrolizumab': 1, 'Let7a': 1, 'miR-199a': 2, 'MIBC': 1, 'nicotine': 2, 'pDCs': 3, 'alpha7nAChR antagonist': 1, 'JAK2 inhibitor': 1, 'Paeonia': 1, 'Paeoniae': 2, 'lactiflora': 1, 'dextran sodium': 1, 'opiate': 1}, 'pain': {'Wilcoxon': 1, 'analgesia': 5, 'analgesic': 3, 'opioid': 3, 'morphine': 1, 'CSM': 1, 'dexamethasone': 2, 'cannabidiol': 2, 'tetrahydrocannabinol': 2, 'midodrine': 1, 'droxidopa': 1, 'nitroglycerin': 1, 'triptans': 1, 'oxygen': 1, 'steroids': 1, 'suboccipital steroid': 1, 'verapamil': 1, 'lithium': 1, 'melatonin': 1, 'topiramate': 1, 'somatostatin receptor agonists': 1, 'nitrous': 1, 'N2O': 4, 'antibiotic': 5, 'Acupotomology': 1, 'Wanfang': 1, 'STS': 1, 'October': 1, 'Embase': 1, 'midazolam': 3, 'fentanyl': 5, 'NPY': 1, 'Mefenamic acid': 1, 'nonsteroidal': 1, 'antipyretic': 1, 'mefenamic acid combined with standard medical care vs. standard medical care plus a placebo in ambulatory patients with coronavirus disease 2019 (COVID19; nasal/oropharyngeal swabs reverse transcriptionPCR test results positive for severe acute respiratory syndrome coronavirus 2)': 1, 'doubleblind': 1, 'mefenamic acid group (P=0.020, KaplanMeier analyses using logrank tests)': 1, 'mefenamic acid plus standard medical care had a': 1, 'mefenamic acid group': 1, 'mefenamic acid markedly reduced the symptomatology and time to reach PASS in ambulatory patients with COVID19': 1, 'mefenamic acid': 1, 'steroid': 2, 'insulin': 1, 'dL.': 1, 'vitamin D': 4, 'vitamin D-deficient osteomalacia': 1, 'calcium': 1, 'gastrinoma': 1, 'pancreaticoduodenectomy': 1, 'chemoradiation': 1, 'LSWT': 5, 'IPSS': 1, 'Antibiotic': 1, 'ceftazidime': 2, 'cefepime': 1, 'Sinomenine': 2, 'sinomenine': 1, 'sinomenine hydrochloride': 4, 'CNKI': 1, 'VIP': 1, 'Pfizer': 2, 'antimicrobials': 1, 'Antibiotics': 1, 'oxacillin': 1, 'teicoplanin': 1, 'daptomycin': 1, 'fosfomycin': 1, 'antibiotics': 3, 'hormone melatonin': 1, 'metabotropic glutamate receptor': 1, 'IONI': 1, 'Photobiomodulation': 1, 'PBMT': 1, 'nitric oxide': 1, 'prostaglandin': 1, 'Marvelon': 1, 'microg': 2, 'ethinyl': 1, 'estradiol': 1, 'desogestrel': 1, 'DSG': 1, 'nitric oxide metabolism)': 1, 'ANCOVA': 1, 'aspirin': 1, 'hydrocortisone': 1, 'Lidocaine': 1, 'Propofol': 1, 'opioids': 2, 'Definisse': 2, 'lidocaine': 7, 'sedation': 1, 'Incisional': 1, 'September': 1, 'Paracetamol': 1, 'Ketorolac': 1, 'Reepithelisation': 1, 'anesthesia': 1, 'chemotherapy': 1, 'Visual Analog Scale (VAS)': 1, 'corticosteroids': 1, 'methylcobalamin': 1}, 'tumor': {'Doxorubicin': 1, 'doxorubicin': 5, 'acyl hydrazine': 1, 'thiourea': 1, 'humanized monoclonal antibody': 1, 'nanoforms': 1, 'chemo': 6, 'methylene blue': 1, 'PD-1 checkpoint blockade further evokes a series of systemic immunity responses that suppress distant tumor growth and the pulmonary metastasis of breast cancer, as well as offer': 1, 'FVIIa': 1, 'LR': 1, 'curcumin': 3, 'Arsenic trioxide (ATO)': 1, 'FAO': 1, 'ctDNA': 2, 'PFS': 5, 'SUVpeak': 1, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'chemotherapy': 9, 'rituximab': 3, 'ibrutinib': 1, 'Lugano': 1, 'IL-6': 1, 'magnesium': 1, 'TE supplements': 1, 'Kyoto': 2, 'FOS': 1, 'IKBKE': 1, 'amlodipine': 1, 'lenvatinib': 2, 'dexamethasone': 1, 'rapamycin': 1, 'BRAF inhibitor': 2, 'PSMA ligands': 1, 'glutamic acid into a lysine residue': 1, 'Lodz': 1, 'Poland': 1, 'chemoembolization': 1, 'irinotecan': 2, 'August': 1, 'iodized oil': 1, 'spondylarthritis': 1, 'nonsteroidal': 1, 'BRAF': 1, 'RSNA': 1, 'nanocarrier': 1, 'beta-cyclodextrin (betaCD)': 1, 'photothermal': 1, 'ZNF384 knockdown models were established in CRC cells': 1, 'MMP2': 1, 'CAFs': 2, 'lactic acid efflux': 1, 'anticancer': 1, 'gastrinoma': 1, 'pancreaticoduodenectomy': 1, 'parotidectomy': 1, 'letrozole': 1, 'capecitabine': 1, 'paclitaxel': 2, 'carboplatin': 1, 'etoposide': 1, 'consolidative': 1, 'sarilumab': 4, 'nivolumab': 6, 'prednisolone': 1, 'sulfasalazine': 2, 'gemcitabine': 1, '6MP': 1, 'azathioprine': 1, 'methotrexate': 1, 'immunosuppressive medications': 1, 'Antibiotic': 1, 'antibiotic': 7, 'EOCRC': 1, 'antibiotics': 1, 'Autophagy': 1, 'recombinant human chemerin': 1, 'chemerin': 1, 'epithelioid blue nevus (EBN)': 1, 'polyphenolic flavonoid with anti-tumor ability. METHODS: Cell viability and proliferation of two cancer cells': 1, 'FMSP': 4, 'IL-2': 1, 'checkpoint inhibitors': 1, 'CRS': 1}, 'deaths': {'oxaliplatin': 5, 'chemotherapy': 25, 'nivolumab': 8, 'capecitabine': 1, 'Nivolumab': 1, 'Erdafitinib': 1, 'urothelial': 1, 'erdafitinib': 6, 'cisplatin': 1, 'hyponatraemia': 1, 'buprenorphine': 11, 'opioid': 11, 'mu opioid agonist': 1, 'opioids': 6, 'full agonist opioids': 1, 'chronic buprenorphine': 1, 'overdoses': 2, 'naloxone': 10, 'Naloxone': 1, 'fluids': 1, 'gemcitabine': 1, 'amino acid transport': 1, 'Lohani': 1, 'anticoagulant medication. Endovascular or open vascular revascularisation': 1, 'anticoagulation': 4, 'nitric oxide': 3, '16,850': 1, 'vitamin D3': 6, 'vitamin D3 supplementation (60': 1, 'vitamin D': 3, 'vitamin K antagonist (VKA)': 1, 'anticoagulant (NOAC)': 1, 'diuretic': 1, 'dexamethasone': 4, 'remdesivir': 1, 'January': 2, 'paclitaxel': 1, 'docetaxel': 2, 'intravitreal': 1, 'ranibizumab': 1, 'Oxycodone': 3, 'oxycodone': 8, 'microg': 1, 'February': 1, '42,956': 1, 'GHTD': 2, 'UEBMI': 1, 'URRBMI': 1, 'ivermectin': 1, 'diethylcarbamazine': 1, 'albendazole': 1, 'azithromycin': 1, 'AZI': 1, '8,375': 1, 'Santobono': 1, 'ACE inhibitors': 2, 'diuretics': 2, 'ARBs': 1, 'Ozyorsk': 1, 'subcohort': 1, 'warfarin': 2, 'nicotine': 1, 'Thessaly': 1, 'Perfluorooctanoic acid (PFOA)': 1, 'Colombia': 1, 'Iran': 1, 'polyvinyl chloride (PVC)': 1, 'ethylene oxide': 1, 'europium hydroxide nanorods': 1, 'vasopressors': 1, 'October': 1, 'Botswana': 1, 'ibuprofen': 1, 'dexmedetomidine': 1, 'phenobarbital': 1, 'tizanidine': 1, 'clonidine': 2, 'gabapentin': 1}, 'inflammation': {'SELENOS': 1, 'Magnoliae': 1, 'trinitrobenzene sulfonic acid (TNBS)-induced ulcerative colitis (UC)': 1, 'TNBS': 1, 'probiotics': 2, 'Akkermansia': 1, 'Blautia': 1, 'Allobaculum': 1, 'Alloprevotella': 1, 'rapamycin': 1, 'FVIIa': 1, 'curcumin': 2, 'agonists': 1, 'glucagon': 1, 'PPAR agonists': 2, 'lanifibranor': 1, 'vitamin D': 1, 'Vitamin A supplementation programs should monitor VA status with biomarkers sensitive': 1, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'IL-6': 4, 'magnesium': 1, 'TE supplements': 1, 'Acupotomology': 1, 'Wanfang': 1, 'STS': 1, 'October': 2, 'Centella': 1, 'cisplatin': 4, 'histopathological': 1, 'CA': 1, 'chemotherapy': 1, 'spondylarthritis': 1, 'rituximab': 1, 'nonsteroidal': 2, 'doxycycline': 1, 'Catalase': 1, 'glutathione peroxidase (GPx) enzymes': 1, 'sodium hydroxide (NaOH)': 1, 'Mefenamic acid': 1, 'antipyretic': 1, 'analgesic': 2, 'mefenamic acid combined with standard medical care vs. standard medical care plus a placebo in ambulatory patients with coronavirus disease 2019 (COVID19; nasal/oropharyngeal swabs reverse transcriptionPCR test results positive for severe acute respiratory syndrome coronavirus 2)': 1, 'doubleblind': 1, 'mefenamic acid group (P=0.020, KaplanMeier analyses using logrank tests)': 1, 'mefenamic acid plus standard medical care had a': 1, 'mefenamic acid group': 1, 'mefenamic acid markedly reduced the symptomatology and time to reach PASS in ambulatory patients with COVID19': 1, 'mefenamic acid': 1, 'PD-1 antibody pembrolizumab': 1, 'betamethasone': 1, 'montelukast': 1, 'salbutamol': 1, 'salmeterol': 1, 'fluticasone': 1, 'anabolic': 1, 'hormone melatonin': 1, 'arginase inhibitor N(omega)': 1, 'nitric oxide': 1, 'recombinant human chemerin': 1, 'chemerin': 1, 'Ilex': 1, 'dimethyl fumarate (DMF)': 1, 'RMSSD': 1, 'luteolin': 1, 'quercetin': 1, 'Immunomodulation': 1, 'aspirin': 2, 'hydroxychloroquine': 1, 'RAC1': 1, 'pharmacodynamics': 1, 'insulin': 3, 'Endpoints': 1, 'BMI': 2, 'MyD88 inhibitor': 1, 'Insulin': 1, 'antibiotics': 3, 'hydrocortisone': 1, 'CLN1': 1, 'CLN10': 1, 'serum glutamic oxaloacetic': 1, 'uric acid': 1, 'malondialdehyde': 2, 'EWAS': 1, 'steroid': 1, 'hypoparathyroidism': 1, 'IL-8': 4, 'vitamin D receptor (VDR, Fok I': 1, 'calcitonin receptor (CALCR': 1, 'estrogen receptor alpha (ESR1, Pvu II': 1, 'rosiglitazone': 1, 'rifampicin': 1, 'polylactic acid (PLA)': 1, 'diphenyltetrazolium bromide (MTT)': 1, 'Citri': 1, 'vitamin E': 1, 'arachidonic acid': 1, 'RyR inhibitor': 1, 'dantrolene': 5, 'Rab8a': 2, 'dimethyl fumarate (DMF)-induced anti-inflammatory and neuroprotective effects in the brain along with improvement in cognitive functions in rats with the ICV-STZ-induced model of AD. To evaluate whether DMF reduces neuroinflammation': 1, 'DMF rat chow': 1, 'minocycline': 1, 'TSCI': 1, 'iron oxide nanoparticles (SPIONs)': 1, 'dimercaptosuccinic acid': 1, 'WNT': 1, 'nicotine': 1, 'CO': 1, 'CSA': 2, 'Ligusticum': 1, 'TMP': 1, 'MIBC': 1, 'NIK mRNAs': 1, 'steroids': 1, 'povidone-iodine forniceal rinses': 1, 'hypochlorous acid': 1, 'alvarezii': 1}, 'breast cancer': {'chemo': 5, 'doxorubicin': 3, 'methylene blue': 1, 'PD-1 checkpoint blockade further evokes a series of systemic immunity responses that suppress distant tumor growth and the pulmonary metastasis of breast cancer, as well as offer': 1, 'LR': 1, 'K inhibitor therapy in ER-positive metastatic patients)': 1, 'CRL': 3, 'Scopus': 1, 'February': 1, 'dmit': 1, 'dsit ligands': 1, 'cisplatin': 4, 'letrozole': 1, 'capecitabine': 4, 'paclitaxel': 2, 'carboplatin': 2, 'etoposide': 1, 'consolidative': 1, 'September': 1, 'Autophagy': 1, 'curcumin': 3, 'RENORT': 1, 'Hypofractionation': 1, 'heparin': 1, 'EORTC': 1, 'pembrolizumab': 1, 'chemotherapy': 26, 'nivolumab': 1, 'ipilimumab': 1, 'docetaxel': 2, 'tamoxifen': 3, 'estradiol': 2, 'estrogen agonist': 1, 'estrogens': 1, 'Aromatase inhibitors (AIs)': 1, 'Olaparib': 1, 'adenosine diphosphate-ribose)': 1, 'prednisone': 1, 'January': 4, 'IMRT': 1, 'GLS': 1, 'somatostatin analogues': 1, 'circRNA': 1, 'mRNAs': 2, 'AUCs': 1, 'Adjuvant chemotherapy': 1, 'CDX-011': 1, 'SUVmean': 1, 'Latinx': 2, 'fulvestrant': 4, 'chemotherapies': 1, 'Fulvestrant': 1, 'folic acid (FA) conjugated chitosan (CS) encapsulated rutin (R) synthesized palladium nanoclusters': 1, 'corticosteroid': 1, 'Eribulin': 1, 'anthracycline': 2, 'eribulin': 2, 'PFS': 1, 'OS': 1, 'trastuzumab': 2, 'taxane': 1, 'oxaliplatin': 1, 'Lapatinib': 2, 'berberine': 1, 'lapatinib': 7, 'capivasertib': 2, 'BBR': 1, '2,542,382': 1, 'Indonesia': 2, 'November': 1, 'Jbeta': 1, 'ctDNA': 1, 'estrogen receptors': 1, 'ERalpha': 1, 'GPR30': 1, 'TGFbeta': 2, 'SpaTAX': 2, 'estrogen': 2, 'nanocarrier': 1, 'iron oxide nanoparticles': 1, 'anticancer': 1, 'interactions': 1, 'chemodrugs': 1, 'PEGylated': 1, 'nonselective interactions': 1, 'free curcumin': 1, 'Annexin': 1, 'free curcumin (p <': 1, 'Hilden': 1, 'ABPI': 1, 'APBI': 1, 'deruxtecan': 1, 'tucatinib': 1, 'Clinicopathological': 1, 'mammaglobin': 1, 'estrogen receptor (ER)': 1, 'progesterone receptor (PR)': 1, 'rapamycin inhibitors': 1, 'sodium iodide symporter': 1, 'pharmacodynamics': 1, 'biodistribution': 1, 'TNBC': 1, 'progesterone receptor (PR) (OR =': 1, '95%CI': 1, 'Aromatase inhibitor': 1, 'aromatase inhibitor-associated bone loss (AIBL)': 1, 'aromatase inhibitors': 1, 'THaBMD': 1}, 'COVID-19 infection': {'ocrelizumab': 1, 'amino acids': 1, 'antibiotics': 2, 'aspirin': 1, 'hydrocortisone': 1, 'voriconazole': 1, '245/1,673': 1, 'steroids': 2, 'cyclophosphamide': 2, 'Pfizer': 2, 'AstraZeneca': 2, 'CYC': 1, 'rituximab': 1, 'January': 1, 'August': 1, 'Embase': 1, 'Scopus': 1, 'February': 4, 'Lohani': 1, '2021;25(12):1382': 1, 'Zirpe': 1, 'immunomodulators': 1, 'tocilizumab': 2, 'LTCF': 1, 'baricitinib': 1, 'KFD': 1, 'vitamin D': 1, 'selenium': 1, 'vitamin B12': 1, 'corticosteroids': 2, 'antifungals': 1, 'HLH': 1, 'chemotherapy': 1, 'Riffa': 1, 'Bahrain': 1, 'Argentina': 1, 'Cohorting': 1, 'clinicoradiological': 1, 'flavonoid silymarin': 1, 'Amanita': 1, 'anticancer': 1, 'silymarin compounds': 1, 'October': 1, 'decompressive craniectomy': 1, 'November': 1, 'Berhampur': 1, 'immunosuppressive therapies': 1, 'BBIBP': 3, 'September': 1, 'CORV': 1, 'tacrolimus': 1, 'benzodiazepines': 1, 'lorazepam': 1, 'ECTs': 1, 'flecainide': 2, 'digoxin': 1, 'amphotericin': 1, 'antifungal': 1, 'itraconazole': 1, 'antipsychotics': 1, 'LAIs': 1, 'propofol': 2, 'lopinavir': 1, 'SSRI': 2, 'antidepressants': 1, 'SSRIs': 1, 'chronic SSRIs': 1, 'Janus kinase inhibitor, therapeutically used for the treatment of rheumatoid arthritis. Recently it has also been approved': 1}, 'infections': {'Antibiotic': 3, 'antibiotic': 18, 'rifampicin': 12, 'immunomodulation': 1, 'tetracycline': 3, 'doxycycline': 1, 'gemifloxacin': 1, 'beta-lactam resistance. Nevertheless, the': 1, 'Iran': 1, 'normal saline': 2, 'injectables': 2, '12/08/2021': 1, 'chloroquine': 1, 'eligilibity': 1, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'AE.BACKGROUND': 1, 'October': 1, 'November': 1, 'ciprofloxacin': 7, 'January': 6, 'hyaluronic acid (HA)': 1, 'thyrotoxic': 1, 'aminoglycosides': 1, 'tobramycin': 6, 'September': 1, 'vasopressor': 1, 'spondylarthritis': 1, 'rituximab': 1, 'nonsteroidal': 1, 'Rubisco': 1, 'amino acids': 1, 'melatonin': 1, 'chemotherapy': 1, 'levofloxacin': 5, 'ceftazidime': 2, 'cefepime': 1, 'interactions': 1, 'Swedish': 1, 'dimethyl fumarate (DMF)': 1, 'DMT': 1, 'phages': 1, 'antibiotics': 18, 'amino acid transport': 1, 'Immunoblotting': 1, 'betadine': 5, 'vancomycin': 4, 'SSI': 6, '30-': 1, 'bevacizumab': 1, 'Vancomycin': 1, 'interferon alpha/peginterferon alpha (IFNalpha/Peg-IFNalpha)': 1, 'Rifabutin': 2, 'rifabutin': 2, 'Baculoviruses Autographa californica multicapsid': 1, 'metagenomic': 1, 'voriconazole': 2, 'acyclovir': 3, 'valacyclovir': 1, 'Immunomodulatory agents (thalidomide and topical imiquimod)': 1, 'thalidomide': 1, 'imiquimod': 1, 'cidofovir': 1, 'Levofloxacin': 1, 'diuretic': 1, 'analgesic': 1, 'epigallocatechin gallate and protected oral epithelial cells': 1, 'cetylpyridinium chloride': 1, 'benzethonium chloride': 1, 'BCG': 1, 'itraconazole': 3, 'isoniazid': 1, 'streptomycin': 1, 'prednisolone': 1, 'interferon-gamma,': 1, 'amoxicillin': 1, 'angiotensin receptor blocker (ARB)': 1, 'diuretics': 1, 'heparin': 2, 'colistin': 2, 'formic acid': 2, 'LHQW': 1, 'AYUSH': 1, 'Unani': 1, 'chlorhexidine gluconate (CHG)': 1, 'povidone-iodine (PVP-I) are increasing. Olanexidine gluconate (OLG)': 1, 'OLG': 1, 'Olanexidine gluconate': 1, 'CRBSI': 1, 'ROS scavenger DMTU': 1, 'n=20': 1, 'blood': 1, 'scavenge reactive oxygen': 1, 'antacids': 1, 'H2 blockers': 1, 'immunomodulators': 1, 'tocilizumab': 2, 'macrolides': 1, 'fluoroquinolones': 1, 'Remeex': 1, 'Treponema': 1, 'Scielo': 1, 'Nrp2': 2, 'nomogram': 1, 'AuROC': 1, 'amikacin': 1, 'carbapenems': 1, 'copper sulfide nanoparticle': 1, 'photothermal': 1, 'carbapenem antibiotics in SAP. METHODS: This meta-analysis of prophylactic carbapenem antibiotics': 1, 'carbapenem antibiotics': 1, 'antibacterials': 1, 'CIP': 1, 'fluoroquinolone': 3, 'adsorbates': 1, 'Malaysia': 1, 'Ethylene oxide (EtO) sterilization, (4) Culture & hold, (5)': 1, 'RTIs': 1, 'Lachnospiraceae': 1, 'Ruminococcaceae': 1, 'Ruminococcus': 1, 'NPIs': 1}}

